Latest 10-K annual reports

Enzon Pharmaceuticals, Inc. reported a net loss of $3.4 million for 2025, driven by merger-related expenses, as it progresses with its acquisition by Viskase Companies, Inc.

Core Scientific, Inc. reports a net loss of $288.6 million for 2025, driven by a strategic pivot from digital asset self-mining to high-density colocation services for AI and HPC workloads, despite increased colocation revenue.

MARA Holdings, Inc. reported a significant net loss of $1.31 billion in 2025, driven by declining Bitcoin prices and increased operating costs, while strategically expanding into AI and high-performance computing.

Nuvation Bio reports its first product revenue from IBTROZI's U.S. launch, but faces increased operating losses and substantial funding needs for its pipeline development.

Limbach Holdings, Inc. announced record annual revenue of $646.8 million and diluted earnings per share of $3.23 for fiscal year 2025, driven by significant growth in its Owner Direct Relationships segment.

Aimco's stockholders adopted a Plan of Sale and Liquidation, leading to significant asset sales and capital distributions, while operational segments show mixed results.

Rocket Companies reported a net loss of $234 million in 2025, despite a 29% increase in loan origination volume, driven by strategic acquisitions of Redfin and Mr. Cooper and higher operating expenses.

JAKKS Pacific, Inc. reported a significant decrease in net sales and net income for the fiscal year ended December 31, 2025, alongside executive employment agreement extensions and new performance-based stock awards.

Supernus Pharmaceuticals reported a net loss of $38.6 million in 2025, driven by the Sage Therapeutics acquisition and increased expenses, despite growth in key product sales and new product launches.

AST SpaceMobile's 2025 annual report details significant progress in its direct-to-device satellite network, including satellite launches, successful testing, and key commercial agreements, alongside substantial capital raises and ongoing net losses.

Tidewater Inc. reported a significant increase in net income for 2025, driven by a substantial deferred tax benefit and higher average day rates, while announcing a major acquisition and new share repurchase program.

Ellington Financial Inc. achieved significant portfolio growth and strong financial performance in 2025, driven by strategic investments and robust segment results.

Senseonics Holdings, Inc. reports increased revenue and gross profit for 2025, driven by the Eversense 365 launch and regaining commercialization rights from Ascensia, despite ongoing net losses and liquidity concerns.

Bone Biologics Corporation reports recurring operating losses and substantial doubt about its ability to continue as a going concern, despite progress in its spinal fusion clinical study and recent capital raises.

Quanterix reports increased revenue driven by strategic acquisitions and progress in Alzheimer's diagnostics, despite a significant rise in net loss and macroeconomic headwinds.

Semrush Holdings, Inc. reported a net loss of $19.5 million for 2025, alongside an 18% revenue increase and ongoing plans for its acquisition by Adobe Inc. for $12.00 per share.

Ready Capital Corporation reported a net loss of $221.1 million for the year ended December 31, 2025, driven by decreased net interest income and increased realized losses, despite strategic acquisitions and a significant bargain purchase gain.

BigBear.ai's 2025 annual report reveals significant strategic acquisitions and a strengthened balance sheet, despite a notable revenue decrease and substantial impairment charges.

Harrow, Inc. reports significant revenue growth in its branded ophthalmic products for 2025, driven by increased marketing efforts for IHEEZO and VEVYE, alongside strategic acquisitions and debt refinancing.

Beacon Financial Corporation reports substantial growth in assets, loans, and deposits following its merger with Brookline Bancorp, Inc., despite increased nonperforming assets and merger-related expenses.

Alamo Group Inc. reported a 2% net sales decrease and a 10% net income decline in 2025, driven by weak vegetation markets and restructuring costs, partially offset by strong industrial equipment demand.

TYRA Biosciences reports significant progress in its FGFR-targeted precision medicine pipeline, advancing three lead candidates into Phase 2 trials and detailing financial results for fiscal year 2025.

Xeris Biopharma Holdings, Inc. reported its first net income since inception in 2025, driven by strong growth in Recorlev sales and overall revenue increase.

Seer, Inc. announced a 17% increase in total revenue to $16.6 million and a 15% reduction in net loss to $73.6 million for the fiscal year ended December 31, 2025, driven by strong product and service sales.

Salesforce reports strong fiscal year 2026 results, driven by AI innovation and the strategic acquisition of Informatica, alongside increased shareholder returns.

Teucrium Commodity Trust reported a decrease in overall net assets for 2025, with most funds experiencing net losses, though the magnitude of losses decreased for several funds.

Wesbanco reports significant asset and income growth in 2025 driven by the PFC acquisition, but diluted earnings per share declined and a material weakness in internal controls was identified.

BRC Inc. reported a 2% revenue increase to $398.3 million in 2025, but gross profit declined 14% and net loss widened significantly to $32.2 million, driven by higher costs and a shift in sales dynamics.

ThredUp Inc. announced significant financial improvements for fiscal year 2025, including a 19.5% revenue increase and a nearly 50% reduction in operating losses, alongside a key loan agreement amendment.

Graphic Packaging Holding Company reports a decline in 2025 net sales and income from operations, driven by divestitures and inflation, alongside significant capital investments and a material weakness in internal controls.